Cancer Molecular Therapeutics

Funder	NATIONAL CANCER INSTITUTE
Recipient Organization	Sanford Burnham Prebys Medical Discovery Institute
Country	United States
Start Date	May 01, 2024
End Date	Apr 30, 2025
Duration	364 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	NIH (US)
Grant ID	`11092506`

Grant Description

The overall goals of the Cancer Molecular Therapeutics (CMT) Program (formerly Aging, Cancer and Immuno-oncology (ACI)) are to engage active collaborations among members of the program to enable new research initiatives and grant programs that will define how the interplay among cancer cells, immune cells, stromal components, and vasculature regulates the growth and metastasis of solid and hematologic malignancies, and to use this knowledge to discover new, more effective cancer treatments.